相关实验视频
Updated: Sep 14, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.5K
肌综合征:将遗传错误与获得的遗传错误
Leighann Henehan1, Elena Rossini2, Isobel Sarah Platt3
1Department of Clinical Neurology, Neurology Department, John Radcliffe Hospital, Oxford, UK Leighann.henehan@ouh.nhs.uk.
Practical neurology
|July 22, 2025
概括
由DOK7变体引起的先天性肌痛综合征 (CMS) 可以在成年人中模仿阴性血清性肌痛严重症. 及时诊断和适当的治疗,避免皮里多斯蒂格,对于患者的改善至关重要.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 先天性肌痛综合征 (CMS) 是一种罕见的遗传神经肌肉结合障碍.
- DOK7变种是CMS的常见原因,有时会被皮里多斯蒂格治疗加剧.
- 成年开始的CMS可能被误诊为获得的严重肌痛性肌痛症.
研究的目的:
- 报告两例与DOK7相关的成年CMS病例,最初被误诊为血清阴性严重肌痛症.
- 强调DOK7 CMS在成年人的诊断挑战和治疗影响.
- 强调考虑CMS在血清阴性肌痛性肌痛症呈现的重要性.
主要方法:
- 两名成年患者的病例报告,肢体腰带软弱进展.
- 对临床病史,诊断工作和治疗反应的审查.
- 基因分析以确定DOK7的病原性变体.
主要成果:
- 两位患者都出现了成人发病,缓慢进展的疲劳性四肢腰带弱点.
- 初步诊断的血清阴性肌痛性肌痛症导致升级免疫抑制疗法和pyridostigmine.
- 患者在停止皮里多斯蒂格和免疫抑制剂后显著改善,并开始服用沙布塔摩尔.
- 基因检测证实了在两个人身上都有DOK7变异.
结论:
- DOK7 CMS应在成人发病的阴性血清性肌痛严重症的差异诊断中考虑.
- 皮里多斯蒂格可以使DOK7 CMS的症状恶化,需要仔细审查药物.
- 及时诊断和有针对性的治疗对于管理DOK7 CMS和改善患者结果至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Muscle Contraction
7.0K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
7.0K

